Survival rate of high-risk neuroblastoma patients treated with next-generation immunotherapy at SJD Barcelona Children's Hospital

Researchers of SJD Barcelona Children's Hospital and of Institut de Recerca Sant Joan de Déu (IRSJD) have published the results of treatment with the humanised anti-GD2 antibody Naxitamab (DanyelzaR) combined with granulocyte-macrophage colony-stimulating factor (GM-CSF; LeukineR) in high-risk neuroblastoma patients.

  1. More than 6% of Europeans suffer from depression

    Dr. Antoni Serrano (Institut de Recerca Sant Joan de Déu) participates in a study led by King's College London and the Hospital del Mar Medical Research Institute where the prevalence of depression among the population of more than 27 European countries has been studied.

  2. Predicted prognosis of one type of childhood cancer by tumour engraftment in mice

    Researchers of the Institut de Recerca Sant Joan de Déu and the SJD Barcelona Children's Hospital have made public their ten-year experience with the development of animal models of paediatric sarcomas

  1. Human milk from women infected and vaccinated for coronavirus has antibodies against COVID-19

    Human milk from infected women and vaccinated for coronavirus has antibodies against COVID-19, according to two published studies in the medRxiv repository and launched by the scientific consortium MilkCorona,

  2. Research identifies six groups in the population more susceptible to the impact of the pandemic

    Dr. Belén Arranz, Dr. Judith Usall i Rodié and Dr. Antoni Serrano from the Institut de Recerca Sant Joan de Déu participate in the project COM-COVID, leds by Dr. Cristina Vilaplana from the Germans Trias i Pujol Research Institute.

  3. Can a newborn’s brain discriminate speech sounds?

    A study by the Institut de Recerca Sant Joan de Déu shows newborns do not fully distinguish different vocal sounds. Researchers created a new methodology to record the neural encoding for these sounds, published in the Nature's open-access journal Scientific Reports.

  4. Supplementing the maternal diet with betaine during lactation may reduce the risk of childhood obesity

    Decreased levels of betaine in breast milk are associated with accelerated growth in babies during the first few months of life, a risk factor for childhood obesity. Study led by a research team from the Institut de Recerca Sant Joan de Déu and SJD Barcelona Children’s Hospital, published in the scientific journal Science Translational Medicine.

  5. The conditions of 70% of people with chronic pain have worsened during the pandemic

    Juan Vicente Luciano and Albert Feliu, Institut de Recerca Sant Joan de Déu, participate in a study that has analysed the factors that can negatively influence people with pain.

  6. Sant Joan de Déu participates in the new Barcelona Medical Photonics Network

    Eight prominent health institutions in the Barcelona area, their research institutes and ICFO join forces through the creation of a network to bring cutting-edge photonic technologies to hospitals.